Heart Failure Therapy in Diabetic Patients
Author Information
Author(s): Frank Edelmann, Rolf Wachter, Hans-Dirk Düngen, Stefan Störk, Annette Richter, Raoul Stahrenberg, Till Neumann, Claus Lüers, Christiane E Angermann, Felix Mehrhof, Götz Gelbrich, Burkert Pieske
Primary Institution: University of Göttingen
Hypothesis
To compare heart failure therapies in diabetic patients with preserved versus impaired systolic ventricular function.
Conclusion
Diabetic patients with HFNEF received less heart failure medication and had poorer blood pressure control compared to those with SHF.
Supporting Evidence
- 90% of diabetic patients with SHF received ACEi/ARB and beta-blockers.
- Diabetic HFNEF patients were less likely to receive ACEi/ARB and beta-blockers.
- Blood pressure control was poorer in diabetic HFNEF patients compared to diabetic SHF patients.
Takeaway
This study found that diabetic patients with a certain type of heart failure don't get as much medicine as those with another type, which makes their blood pressure harder to control.
Methodology
The study analyzed data from 3304 heart failure patients across 9 studies, focusing on medication use and blood pressure control.
Potential Biases
Potential bias due to the majority of patients being from studies focused on SHF.
Limitations
The study is cross-sectional and may not represent all diabetic heart failure patients, as many included had SHF.
Participant Demographics
Mean age 63 years, 994 patients had diabetes, 22% had preserved ejection fraction.
Statistical Information
P-Value
p<0.001
Confidence Interval
95%
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website